Monoclonal Antibody IV Therapy
COVID-19 Treatment

Monoclonal antibody IV treatments help support the immune system to help fight a Covid-19 infection.

Monoclonal Antibody Treatment – Bebtelovimab

Monoclonal antibodies are lab-created proteins that mimic the immune system’s ability to fight off viruses and diseases. Bebtelovimab is a monoclonal antibody therapy directed against SARS-CoV-2. It is designed to block the virus’ attachment and entry into human cells.

This monoclonal antibody treatment is shown to:

  • Reduce the risk of hospitalization
  • Reduce symptom severity

Price: $799 – $1,999

*Cost is for the in-home service; medication is free

Who is eligible to receive monoclonal antibody IV therapy?

Monoclonal antibody treatments are available for individuals who:

  • Have tested positive for Covid-19
  • Have mild to moderate symptoms
  • Are at high risk for developing complications
  • Are vaccinated or unvaccinated
  • Are 12 years of age or older and weigh at least 88 pounds

Book Monoclonal Antibody IV Therapy

Not ready to book? Contact us here.

Returning customer? Click here to login

Frequently Asked Questions

What are monoclonal antibodies?

Monoclonal antibodies are lab-created proteins that mimic the ones our bodies produce to fight viruses. The antibodies defend the body by blocking Covid-19 viruses from attaching to human cells.

What is Bebtelovimab?

Bebtelovimab, pronounced: beb-te-LOV-i-mab

Bebtelovimab is a neutralizing antibody drug. When there’s a virus in your body, like COVID-19, your immune system makes antibodies to fight it off. But it takes time for your body to make antibodies for a new virus — and in the meantime, you could get very sick. Bebtelovimab contains man made antibodies to help fight the virus. They do not have any COVID-19 virus in them.

Who is not eligible for this treatment?

Bebtelovimab is not authorized for use in people who:

  • are hospitalized due to COVID-19
  • require oxygen therapy and/or respiratory support due to COVID-19
  • require an increase in baseline oxygen flow rate and/or respiratory support due to COVID-19 and are on chronic oxygen therapy and/or respiratory support due to underlying non-COVID-19 related comorbidity.

How is Monoclonal Antibody Therapy administered?

Bebtelovimab will be given as an injection through a vein (intravenously or IV) over at least 30 seconds. You will be observed for at least 1 hour after you receive Bebtelovimab.

Where can Concierge MD administer the treatment?

In order to preserve the safety and comfort of our patients, we offer this treatment in a house call setting.

What are the important possible side effects of Bebtelovimab?

  • Allergic reactions. Allergic reactions can happen during and after injection with Bebtelovimab. Tell your healthcare provider right away if you or your child develop any of the following signs and symptoms of allergic reaction: fever, difficulty breathing, low oxygen level in your blood, chills, tiredness, fast or slow heart rate, chest discomfort pain, weakness, confusion, nausea, headache, shortness of breath, low or high blood pressure, wheezing, swelling of your lips, face, or throat, rash including hives, itching, muscle aches, dizziness, feeling faint, and sweating. These reactions may be severe or life threatening. 
  • The side effects of receiving any medicine by vein may include brief pain, bleeding, bruising of the skin, soreness, swelling, and possible infection at the injection site.

Experience Care with ConciergeMD

ConciergeMD offers coverage throughout the United States.